We are receiving a lot of questions about relevant analyses in the Analyse-it Method Validation edition to help in evaluating new diagnostic tests in the fight against COVID-19. Below are some quick links that will help, but contact us if you have questions - we are working as normal.
Also see our latest blog post: Sensitivity/Specificity and The Importance of Predictive Values for a COVID-19 test
Today we’re delighted to publish the second case study into the use of Analyse-it.
The case study features a national clinical laboratory in the USA that offers more than 2,000 tests and combinations to major commercial and government laboratories. They use Analyse-it to determine analytical performance of automated immunoassays for some of the industry’s leading in-vitro diagnostic device makers -- including Abbott Diagnostics, Bayer Diagnostics, Beckman Coulter and Roche Diagnostics.
Unfortunately we cannot name the end-user, or the organisation she works for, in the case study. Although she was delighted to feature in the case study, at final approval her organisation's committee preferred the names be withheld. Thankfully they have allowed us to use the case study, albeit anonymously.
You can read the case study online now or download the Adobe PDF version.
We would love to feature more customer stories in case studies. If you can get approval to participate – which we realise is very difficult in many industries – and have 20 minutes to spare for a telephone interview, please contact us at firstname.lastname@example.org.
Comments are now closed.